Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16727 http://scihub22266oqcxt.onion/10.1111/bjh.16727 32304577!7264537!32304577     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 189 (5): 846-847 Nephropedia Template TP {{tp|p=32304577|t=2020. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action |pdf=|usr=}}{{32304577}} gab.com Text Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32304577 #FOAvip Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy, namely disseminated intravascular coagulation, which has a rather prothrombotic character with high risk of venous thromboembolism. The incidence of venous thromboembolism among COVID-19 patients in intensive care units appears to be somewhat higher compared to that reported in other studies including such patients with other disease conditions. D-dimer might help in early recognition of these high-risk patients and also predict outcome. Preliminary data show that in patients with severe COVID-19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis-induced coagulopathy criteria or with markedly elevated d-dimer. Recent recommendations suggest that all hospitalized COVID-19 patients should receive thromboprophylaxis, or full therapeutic-intensity anticoagulation if such an indication is present. Twit Text FOAVip Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32304577 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32304577 #FOAvip English Wikipedia <ref>{{Cite pmid|32304577}}</ref> Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action #MMPMID32304577 Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K Br J Haematol 2020[Jun]; 189 (5): 846-847 PMID32304577show ga Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy, namely disseminated intravascular coagulation, which has a rather prothrombotic character with high risk of venous thromboembolism. The incidence of venous thromboembolism among COVID-19 patients in intensive care units appears to be somewhat higher compared to that reported in other studies including such patients with other disease conditions. D-dimer might help in early recognition of these high-risk patients and also predict outcome. Preliminary data show that in patients with severe COVID-19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis-induced coagulopathy criteria or with markedly elevated d-dimer. Recent recommendations suggest that all hospitalized COVID-19 patients should receive thromboprophylaxis, or full therapeutic-intensity anticoagulation if such an indication is present. |*Betacoronavirus[MESH] |*Coronavirus Infections/blood/drug therapy/epidemiology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/blood/drug therapy/epidemiology[MESH] |*Venous Thromboembolism/blood/drug therapy/epidemiology/virology[MESH] |Anticoagulants/*administration & dosage[MESH] |COVID-19[MESH] |Disseminated Intravascular Coagulation/blood/drug therapy/epidemiology/virology[MESH] |Female[MESH] |Fibrin Fibrinogen Degradation Products/*metabolism[MESH] |Humans[MESH] |Incidence[MESH] |Male[MESH] |Risk Factors[MESH]Thromboembolic risk and anticoagulant therapy in COVID-19 patients: em(epmc).pdf DeepDyve Pubget Overpricing